← Back to FR Documents
Proposed Rule

Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act

Document Details

Document Number2024-05801
TypeProposed Rule
PublishedMar 20, 2024
Effective Date-
RIN0910-AI31
Docket IDDocket No. FDA-2023-N-0061
Text FetchedNo

Agencies & CFR References

Agency Hierarchy:
Health and Human Services Department→Food and Drug Administration
CFR References:
21 CFR 216

Linked CFR Parts

PartNameAgency
21 CFR 216 Human Drug Compounding... -

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

View on FederalRegister.gov Search Regulations.gov

Full Text

Text Not Yet Fetched

The full text for this document hasn't been fetched yet. The system will automatically retrieve it during the next processing cycle.